|
Charles Denham (born in 1955 in San Bernardino, California) is a patient advocate and currently the CEO of Health Care Concepts Corporation (HCC). He previously served as the Chairman of the Texas Medical Institute of Technology , an independent medical nonprofit organization. Biography Charles Denham graduated with a B.M.S. and an M.D. from the University of Alberta. He completed his medical residency in radiation oncology at Baylor College of Medicine. Denham began his career as a radiation oncologist in Austin, Texas. Denham has been an adjunct Professor at the Mayo Clinic College of Medicine in Health Services Engineering and was the Editor-in-Chief of the Journal of Patient Safety from 2011-2014. He has been a Chairman of The Leapfrog Group Safe Practices Program. He is the producer of a global series of documentaries, including Chasing Zero: Winning the War on Healthcare Harm and Surfing the Healthcare Tsunami: Bring Your Best Board. His article, co-authored with Captain Sully Sullenberger, addresses the value that aviation best practices can have on healthcare. Dr. Denham has been a member of The Experts healthcare panel of the Wall Street Journal, where he served as a regular contributor. Publications He served as the Editor-in-Chief of the Journal of Patient Safety Controversy In January 2014, the United States Department of Justice reached a USD $40.1 million settlement with CareFusion, a medical products company. The Department of Justice alleged that CareFusion paid Denham USD $11.6 million to influence the Safe Practices Committee at the National Quality Forum to recommend, promote and arrange for the purchase of that company's products. An analysis by ProPublica reported that the National Quality Forum's final 2010 guidelines, currently in effect, still recommend 2% Chlorhexadine and 70% alcohol, which is the formulation of ChloraPrep.The NQF agrees that this is consistent with current Centers for Disease Control and Prevention (CDC) guidelines.
|
|
|